Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for Post-Cardiac Arrest Dysfunction
NCT05956431Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of levosimendan in cardiac arrest (SCA), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
levosimendan
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05956431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05956431.